Chemical Structure (Torisel 01)
Torisel Kit
Product Images NDC 0008-1179
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Torisel (NDC 0008-1179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Torisel 02)
Logo (Torisel 03)
This is a description of a company called Wyeth Pharmaceuticals Inc, which is a subsidiary of Pfizer Inc located in Philadelphia, PA 19101.*
Principal Display Panel (25 mg/mL Vial Label)
This is a description of Temsirolimus injection, a medication that comes in a single-use vial of 25 mg/mL. The text provides instructions for preparing the medication for IV infusion, including dilution with a specific volume of a diluent and then mixing the solution with sodium chloride injection. The medication needs to be refrigerated and is distributed by Wyeth Pharma.*
Principal Display Panel (2.2 mL Vial Label)
This is a description of a diluent used for the drug TORISEL (temsirolimus) injection. The diluent comes in a 2 mL single-use vial and is only for dilution purposes. The vial should be refrigerated and handled with caution as it is cytotoxic. The usage details can be found in the insert provided. The diluent is made in Italy and should not be directly administered. The text also includes NDC (National Drug Code) numbers for the diluent and TORISEL.*
Principal Display Panel (Kit Carton)
This is a description of Torisel, a drug used for intravenous infusion. The package contains 25 mg/mL of temsirolimus injection and an additional diluent of 22 mL. The diluent requires careful handling and refrigeration before administration. The package insert provides instructions for dilution and recommended dosage. It is advised to protect the drug from light. The concentration of the drug is concentrated and requires two dilutions before administration. There is an overfill of 0.2 mL in each vial.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
